T2DM: Type 2 Diabetes Mellitus Industry-sponsored trials are actively underway (or have already been completed) exploring the potential for GLP-1 based therapies in a range of new indications
The potential patient population may also be segmented across different weight-loss needs, rather than addressed with a one-size-fits-all approach that we incorporated into our previous projection
Liposomal glutathione supplementation restores Th1 cytokine response to Mycobacterium tuberculosis infection in HIV-infected individuals
Why Lifestyle Still Matters Even when these medications are effective, they work best when combined with healthy lifestyle habits
Long-lasting Effects: Retatrutide has a longer half-life, which allows for more stable blood levels and more consistent weight loss results
A provider may recommend semaglutide if: You prefer a medication with a longer track record You have specific cardiovascular considerations You respond well to GLP-1 therapy A provider may recommend tirzepatide if: Maximizing weight loss is a primary goal You have insulin resistance You qualify medically and can tolerate the medication Because every patient responds differently, a personalized consultation is essential
